Published in Psychopharmacology (Berl) on June 25, 2010
Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev (2014) 1.37
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev (2015) 1.06
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in rats. BMC Neurosci (2012) 0.87
Nicotinic excitation of serotonergic projections from dorsal raphe to the nucleus accumbens. J Neurophysiol (2011) 0.86
Reward processing by the dorsal raphe nucleus: 5-HT and beyond. Learn Mem (2015) 0.82
Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. Psychopharmacology (Berl) (2014) 0.81
Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine. Psychopharmacology (Berl) (2011) 0.79
Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists. Psychopharmacology (Berl) (2016) 0.79
Serotonin2C receptors and drug addiction: focus on cocaine. Exp Brain Res (2013) 0.78
5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech (2016) 0.77
Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats. J Sex Med (2016) 0.76
Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats. Psychopharmacology (Berl) (2015) 0.75
C4 phenyl aporphines with selective h5-HT(2B) receptor affinity. Bioorg Med Chem Lett (2015) 0.75
Adolescent Female Cannabinoid Exposure Diminishes the Reward-Facilitating Effects of Δ(9)-Tetrahydrocannabinol and d-Amphetamine in the Adult Male Offspring. Front Pharmacol (2017) 0.75
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats. Psychopharmacology (Berl) (2014) 0.75
Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol (1954) 6.65
The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev (2005) 3.17
Addictive drugs and brain stimulation reward. Annu Rev Neurosci (1996) 3.12
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc (2007) 2.63
Drug-activation of brain reward pathways. Drug Alcohol Depend (1998) 2.53
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol (2006) 2.35
Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res (1994) 2.21
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther (2006) 2.03
5-HT receptor regulation of neurotransmitter release. Pharmacol Rev (2007) 1.79
New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol (2007) 1.70
Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog Brain Res (2008) 1.62
Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology (2002) 1.49
Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl) (2002) 1.42
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci (2004) 1.39
The curve-shift paradigm in self-stimulation. Physiol Behav (1986) 1.38
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. Curr Drug Abuse Rev (2008) 1.26
Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology (2007) 1.26
Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol (2007) 1.26
Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci (2001) 1.26
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res (1986) 1.22
Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther (2000) 1.21
Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol (2007) 1.20
Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem (2006) 1.19
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther (2000) 1.18
Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific. J Neurosci (2010) 1.17
Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience (2007) 1.16
Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience (2007) 1.16
Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther (1995) 1.16
Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology (2007) 1.13
Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) (2000) 1.07
Evaluation of reward processes in an animal model of depression. Psychopharmacology (Berl) (2006) 1.07
The serotonergic system and its role in cocaine addiction. Pharmacol Rep (2005) 1.05
Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology (2004) 1.05
Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology (1995) 1.04
Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci (2002) 1.04
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther (2004) 1.03
Role of serotonin(2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav (2002) 1.03
Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience (2002) 1.02
Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. J Pharmacol Exp Ther (2003) 1.01
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.01
Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology (2007) 1.01
In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology (2004) 0.99
The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology (Berl) (2009) 0.98
Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology (2004) 0.97
Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend (2005) 0.95
Electrolytic lesions of the habenula attenuate brain stimulation reward. Behav Brain Res (2007) 0.95
An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour. Pharmacol Biochem Behav (2002) 0.95
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats. Neurotoxicology (2008) 0.94
Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychopharmacology (Berl) (2000) 0.94
Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology (Berl) (2005) 0.91
Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol Sci (2006) 0.91
Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function. J Comp Physiol Psychol (1974) 0.90
Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward. Neuropsychopharmacology (2006) 0.89
Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Res Monogr (1985) 0.89
Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol Rep (2005) 0.87
Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology (Berl) (2001) 0.87
Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation. Psychopharmacology (Berl) (1996) 0.86
Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine. Synapse (1997) 0.86
Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. Psychopharmacology (Berl) (2008) 0.86
Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. Int J Neuropsychopharmacol (2008) 0.85
Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats. Synapse (2009) 0.85
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res (2003) 0.85
Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology (1999) 0.84
Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav (2002) 0.84
Fitting intracranial self-stimulation data with growth models. Behav Neurosci (1987) 0.84
Simultaneous anhedonia and exaggerated locomotor activation in an animal model of depression. Psychopharmacology (Berl) (2009) 0.84
Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) (2002) 0.82
The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder. Int J Neuropsychopharmacol (2008) 0.82
Serotonin-like immunoreactive cells and fibres in the rat ventromedial mesencephalic tegmentum. Brain Res Bull (1989) 0.82
Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens. Brain Res (1998) 0.81
Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav Brain Res (2008) 0.80
Effects of concomitant motor reactions on the measurement of rewarding efficacy of brain stimulation. Behav Neurosci (1987) 0.80
A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation. Physiol Behav (1985) 0.79
Effects of cocaine and GBR-12909 on brain stimulation reward. Pharmacol Biochem Behav (1994) 0.79
Comparison of intracranial self-stimulation evoked from lateral hypothalamus and ventral tegmentum: analysis based on stimulation parameters and behavioural response characteristics. Brain Res Bull (1996) 0.79
Rewarding electrical brain stimulation: similar thresholds for Flinders Sensitive Line Hypercholinergic and Flinders Resistant Line Hypocholinergic rats. Physiol Behav (1996) 0.78
Quetiapine blocks cocaine-induced enhancement of brain stimulation reward. Behav Brain Res (2009) 0.78
Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward. Brain Res (1997) 0.76
Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. Neuropsychopharmacology (2001) 0.76
Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy. Hum Psychopharmacol (2009) 1.00
CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl) (2004) 0.96
Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol (2007) 0.90
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol (2010) 0.90
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. Int J Neuropsychopharmacol (2013) 0.89
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus. Addict Biol (2012) 0.86
Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) (2006) 0.86
Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine. Int J Neuropsychopharmacol (2008) 0.85
WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res (2003) 0.85
Multiple sclerosis, cannabinoids, and cognition. J Neuropsychiatry Clin Neurosci (2008) 0.81
Efficacy of the atypical antipsychotic aripiprazole in d-amphetamine-based preclinical models of mania. Int J Neuropsychopharmacol (2010) 0.81
Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder. Int J Neuropsychopharmacol (2012) 0.79
Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm. Eur Neuropsychopharmacol (2008) 0.78
5-HT2C receptor involvement in the control of persistence in the reinforced spatial alternation animal model of obsessive-compulsive disorder. Behav Brain Res (2013) 0.78
Chronic WIN55,212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat. Behav Brain Res (2010) 0.77
Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats. Psychopharmacology (Berl) (2014) 0.75
Use of cannabis enhances attentional inhibition. Hum Psychopharmacol (2012) 0.75